OM Investors Have Opportunity to Lead Outset Medical, Inc. Securities Fraud Lawsuit

Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Outset Medical, Inc. (NASDAQ: OM) between August 1, 2022 and August 7, 2024, both dates inclusive (the “Class Period”) of the important October 28, 2024 lead plaintiff deadline. https://mma.prnewswire.com/media/405060/Rosen_Law_Logo.jpg So What: If you purchased Outset Medical securities during the Class Period […]

SkylineDx Announces Data from Largest Prospective Multi-Center Melanoma Gene Expression Profiling Trial at 21st International Congress of the Society for Melanoma Research

The Merlin test (CP-GEP) stratifies melanoma patients based on risk for sentinel lymph node (SLN) metastasis, offering a powerful tool for risk-based decision-making. SkylineDx, an innovative diagnostics company specializing in the research and development of molecular diagnostics for oncology, inflammatory, and infectious diseases, announced today new data from the MERLIN_001 prospective US multi-center trial, the

ROSEN, A RANKED AND LEADING FIRM, Encourages iLearningEngines, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AILE

NEW YORK, Oct. 13, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of iLearningEngines, Inc. (NASDAQ: AILE) between April 22, 2024 and August 28, 2024, both dates inclusive (the “Class Period”). A class action lawsuit

CXM Investors Have Opportunity to Lead Sprinklr, Inc. Securities Fraud Lawsuit

https://mma.prnewswire.com/media/405060/Rosen_Law_Logo.jpg Why:Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sprinklr, Inc. (NYSE: CXM) between March 29, 2023 and June 5, 2024, both dates inclusive (the “Class Period”), of the importantOctober 15, 2024 lead plaintiff deadline. So what:If you purchased Sprinklr securities during the Class Period you may be entitled

Prime Minister announces new Lieutenant Governor of Nova Scotia

The Prime Minister, JustinTrudeau, today announced the appointment of Mike Savage as the new Lieutenant Governor of Nova Scotia. Mike Savage is a respected former parliamentarian, mayor, and business leader with a lifelong commitment to serving the people of Nova Scotia. He was the Member of Parliament for Dartmouth-Cole Harbour for seven years and the

CyberCharge Launches Telegram MINI APP: Expanding Decentralized Energy and Consumer Networks

Singapore, Oct. 13, 2024 (GLOBE NEWSWIRE) — CyberCharge, a blockchain-driven energy platform, today announced the launch of its Telegram MINI APP, marking a key step in expanding its decentralized energy and consumer networks. The MINI APP aims to transition 200,000 early adopters into a broader user base of over 20 million Web2 users, positioning CyberCharge

ARC Document Solutions, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / October 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in ARC Document Solutions, Inc. ("ARC Document Solutions" or "the Company") (NYSE:ARC) for potential breaches of fiduciary duty on the part of its directors and

Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Affected Shareholders Are Urged To Reach Out To The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / October 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Verve Therapeutics, Inc. ("Verve" or "the Company") (NASDAQ:VERV) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by

Sage Therapeutics, Inc. Is Being Sued For Violating Securities Laws And Affected Shareholders Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / October 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Sage Therapeutics, Inc. ("Sage" or "the Company") (NASDAQ:SAGE) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by

Scroll to Top